Invesco’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.8B | Sell |
41,580,823
-1,876,985
| -4% | -$263M | 0.57% | 25 |
|
|
2025
Q4 | $5.33B | Buy |
43,457,808
+28,318,127
| +187% | +$3.44B | 0.5% | 31 |
|
|
2025
Q3 | $1.68B | Buy |
15,139,681
+1,618,453
| +12% | +$184M | 0.26% | 51 |
|
|
2025
Q2 | $1.5B | Buy |
13,521,228
+3,394,330
| +34% | +$361M | 0.26% | 57 |
|
|
2025
Q1 | $1.13B | Sell |
10,126,898
-1,151,017
| -10% | -$119M | 0.21% | 81 |
|
|
2024
Q4 | $1.04B | Buy |
11,277,915
+1,292,399
| +13% | +$116M | 0.19% | 90 |
|
|
2024
Q3 | $837M | Sell |
9,985,516
-82,106
| -0.8% | -$6.27M | 0.16% | 131 |
|
|
2024
Q2 | $691M | Sell |
10,067,622
-1,212,343
| -11% | -$80.9M | 0.15% | 142 |
|
|
2024
Q1 | $826M | Sell |
11,279,965
-368,836
| -3% | -$28.4M | 0.18% | 111 |
|
|
2023
Q4 | $944M | Buy |
11,648,801
+1,285,442
| +12% | +$100M | 0.22% | 75 |
|
|
2023
Q3 | $777M | Sell |
10,363,359
-546,678
| -5% | -$42M | 0.21% | 90 |
|
|
2023
Q2 | $841M | Buy |
10,910,037
+739,576
| +7% | +$59M | 0.22% | 87 |
|
|
2023
Q1 | $844M | Buy |
10,170,461
+286,994
| +3% | +$23.8M | 0.24% | 78 |
|
|
2022
Q4 | $848M | Buy |
9,883,467
+665,849
| +7% | +$52.7M | 0.25% | 66 |
|
|
2022
Q3 | $569M | Buy |
9,217,618
+419,902
| +5% | +$26.5M | 0.18% | 115 |
|
|
2022
Q2 | $544M | Buy |
8,797,716
+1,093,988
| +14% | +$67.7M | 0.16% | 131 |
|
|
2022
Q1 | $458M | Buy |
7,703,728
+276,005
| +4% | +$17.6M | 0.12% | 206 |
|
|
2021
Q4 | $539M | Buy |
7,427,723
+455,661
| +7% | +$31.4M | 0.13% | 175 |
|
|
2021
Q3 | $487M | Buy |
6,972,062
+399,598
| +6% | +$28.1M | 0.12% | 198 |
|
|
2021
Q2 | $453M | Buy |
6,572,464
+784,818
| +14% | +$52.4M | 0.11% | 219 |
|
|
2021
Q1 | $374M | Buy |
5,787,646
+1,185,350
| +26% | +$76.4M | 0.1% | 247 |
|
|
2020
Q4 | $268M | Buy |
4,602,296
+341,700
| +8% | +$20.6M | 0.08% | 325 |
|
|
2020
Q3 | $269M | Sell |
4,260,596
-2,128,881
| -33% | -$148M | 0.09% | 266 |
|
|
2020
Q2 | $492M | Sell |
6,389,477
-1,727,329
| -21% | -$132M | 0.18% | 123 |
|
|
2020
Q1 | $607M | Sell |
8,116,806
-3,088,817
| -28% | -$213M | 0.26% | 85 |
|
|
2019
Q4 | $728M | Sell |
11,205,623
-11,794,288
| -51% | -$768M | 0.23% | 91 |
|
|
2019
Q3 | $1.46B | Buy |
22,999,911
+24,601
| +0.1% | +$1.61M | 0.38% | 34 |
|
|
2019
Q2 | $1.55B | Buy |
22,975,310
+3,418,193
| +17% | +$225M | 0.4% | 30 |
|
|
2019
Q1 | $1.27B | Sell |
19,557,117
-191,019
| -1% | -$12.7M | 0.43% | 28 |
|
|
2018
Q4 | $1.24B | Buy |
19,748,136
+2,242,476
| +13% | +$157M | 0.47% | 26 |
|
|
2018
Q3 | $1.35B | Sell |
17,505,660
-334,665
| -2% | -$25.3M | 0.43% | 29 |
|
|
2018
Q2 | $1.26B | Buy |
17,840,325
+1,688,015
| +10% | +$119M | 0.42% | 29 |
|
|
2018
Q1 | $1.22B | Sell |
16,152,310
-1,396,690
| -8% | -$111M | 0.46% | 29 |
|
|
2017
Q4 | $1.26B | Sell |
17,549,000
-262,537
| -1% | -$19.9M | 0.45% | 25 |
|
|
2017
Q3 | $1.44B | Buy |
17,811,537
+756,802
| +4% | +$57.9M | 0.53% | 20 |
|
|
2017
Q2 | $1.21B | Sell |
17,054,735
-1,098,560
| -6% | -$73.1M | 0.38% | 42 |
|
|
2017
Q1 | $1.23B | Buy |
18,153,295
+634,099
| +4% | +$44.6M | 0.4% | 38 |
|
|
2016
Q4 | $1.25B | Sell |
17,519,196
-123,767
| -0.7% | -$9.2M | 0.42% | 36 |
|
|
2016
Q3 | $1.4B | Sell |
17,642,963
-1,099,362
| -6% | -$89.3M | 0.48% | 31 |
|
|
2016
Q2 | $1.56B | Sell |
18,742,325
-2,590,417
| -12% | -$230M | 0.57% | 21 |
|
|
2016
Q1 | $1.96B | Buy |
21,332,742
+1,735,224
| +9% | +$156M | 0.8% | 16 |
|
|
2015
Q4 | $1.98B | Sell |
19,597,518
-924,342
| -5% | -$96.2M | 0.79% | 15 |
|
|
2015
Q3 | $2.02B | Buy |
20,521,860
+571,756
| +3% | +$63.5M | 0.85% | 12 |
|
|
2015
Q2 | $2.34B | Sell |
19,950,104
-314,655
| -2% | -$34.4M | 0.92% | 7 |
|
|
2015
Q1 | $1.99B | Sell |
20,264,759
-1,207,487
| -6% | -$123M | 0.77% | 12 |
|
|
2014
Q4 | $2.02B | Sell |
21,472,246
-5,985,320
| -22% | -$619M | 0.78% | 13 |
|
|
2014
Q3 | $2.92B | Sell |
27,457,566
-1,153,318
| -4% | -$113M | 1.17% | 4 |
|
|
2014
Q2 | $2.37B | Sell |
28,610,884
-2,570,195
| -8% | -$200M | 0.93% | 4 |
|
|
2014
Q1 | $2.21B | Sell |
31,181,079
-181,354
| -0.6% | -$14.2M | 0.9% | 7 |
|
|
2013
Q4 | $2.36B | Buy |
31,362,433
+1,144,320
| +4% | +$79.7M | 0.94% | 8 |
|
|
2013
Q3 | $1.9B | Buy |
30,218,113
+594,238
| +2% | +$35.5M | 0.83% | 10 |
|
|
2013
Q2 | $1.52B | Buy |
+29,623,875
| New | +$1.54B | 0.71% | 18 |
|
Other funds holding GILD
VCM
VPM
Invesco's GILD Position: Q1 2026 in Review
Invesco reduced its Gilead Sciences (GILD) stake by 4.3% in Q1 2026, selling an estimated $263M and leaving 41,580,823 shares worth $5.8B. The position accounts for 0.57% of the portfolio, ranked #25.
Invesco first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Invesco held 41,580,823 shares of Gilead Sciences worth $5.8B as of Q1 2026.
- Invesco sold 1,876,985 Gilead Sciences shares in Q1 2026, an estimated $263M.
- Gilead Sciences made up 0.57% of Invesco's portfolio in Q1 2026, its #25 holding.
- Invesco first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.